Welcome to Consumer Reports Advocacy

For 85 years CR has worked for laws and policies that put consumers first. Learn more about CR’s work with policymakers, companies, and consumers to help build a fair and just marketplace at TrustCR.org

In the six months following the September removal of Vioxx from the market, prescriptions for the relatively expensive, brand-name pain reliever Mobic spiked by 136 percent – the most of any alternative to Vioxx – while prescriptions for low-cost ibuprofen rose 28 percent, according to an analysis by Consumer Reports Best Buy Drugs.
Click here to download a full copy of the report, which is embargoed for the media until 6 p.m. EST, Thursday, June 1.